Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion type Assertion NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_head.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion description "[In addition, the OR of the patients with CHB having the IL-10-592 C/C variant developing chronic hepatitis was 2.77 (95%CI = 1.13-4.57) when compared with that of the patients with the IL-10-592 A/A variant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_provenance.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion evidence source_evidence_literature NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_provenance.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion SIO_000772 25501140 NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_provenance.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion wasDerivedFrom befree-2016 NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_provenance.
- NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_assertion wasGeneratedBy ECO_0000203 NP1247476.RAhlgyksML0WSL2uBqox1CMkeFhe_FgL1YR2SzdAiWVmc130_provenance.